Original language | English (US) |
---|---|
Pages (from-to) | 1428 |
Number of pages | 1 |
Journal | Diabetes |
Volume | 63 |
Issue number | 4 |
DOIs |
|
State | Published - Apr 2014 |
Externally published | Yes |
Flavonoid apigenin is an inhibitor of the NAD+ase CD38: Implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome (Diabetes (2013) 62 (1084-1093))
Carlos Escande, Veronica Nin, Nathan L. Price, Verena Capellini, Ana P. Gomes, Maria Thereza Barbosa, Luke O'Neil, Thomas A. White, David A. Sinclair, Eduardo N. Chini
Research output: Contribution to journal › Comment/debate › peer-review